6 Committee comments

6 Committee comments

6.1 The Committee noted that if transanal total mesorectal excision (TaTME) is used for treating benign disease, the quality of mesorectal excision is not an important issue and the outcome measures are different to those for treating malignancy.

  • National Institute for Health and Care Excellence (NICE)